Trop-Shock DFT-testing Versus None
Launched by DEUTSCHES HERZZENTRUM MUENCHEN · Oct 27, 2010
Trial Information
Current as of June 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ICD-Implantation in patients with coronary artery disease or dilative cardiomyopathy
- Exclusion Criteria:
- • Atrial fibrillation with inappropriate anticoagulation
About Deutsches Herzzentrum Muenchen
Deutsches Herzzentrum München (German Heart Center Munich) is a leading institution in cardiovascular medicine, dedicated to advancing research, treatment, and education in heart health. Affiliated with the Technical University of Munich, the center specializes in innovative clinical trials aimed at improving diagnostic and therapeutic approaches for heart diseases. With a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to patient-centered care, Deutsches Herzzentrum München is at the forefront of developing novel interventions and enhancing clinical outcomes in cardiovascular health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
München, Bavaria, Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials